Literature DB >> 26771861

The Medicinal Chemistry of Dengue Virus.

Mira A M Behnam1, Christoph Nitsche1, Veaceslav Boldescu1,2, Christian D Klein1.   

Abstract

The dengue virus and related flaviviruses are an increasing global health threat. In this perspective, we comment on and review medicinal chemistry efforts aimed at the prevention or treatment of dengue infections. We include target-based approaches aimed at viral or host factors and results from phenotypic screenings in cellular assay systems for viral replication. This perspective is limited to the discussion of results that provide explicit chemistry or structure-activity relationship (SAR), or appear to be of particular interest to the medicinal chemist for other reasons. The discovery and development efforts discussed here may at least partially be extrapolated toward other emerging flaviviral infections, such as West Nile virus. Therefore, this perspective, although not aimed at flaviviruses in general, should also be able to provide an overview of the medicinal chemistry of these closely related infectious agents.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26771861     DOI: 10.1021/acs.jmedchem.5b01653

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  30 in total

Review 1.  Therapeutic Approaches for Zika Virus Infection of the Nervous System.

Authors:  Rachel P M Abrams; Jamie Solis; Avindra Nath
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Undersampling: case studies of flaviviral inhibitory activities.

Authors:  Stephen J Barigye; José Manuel García de la Vega; Juan A Castillo-Garit
Journal:  J Comput Aided Mol Des       Date:  2019-11-26       Impact factor: 3.686

3.  Smp76, a Scorpine-Like Peptide Isolated from the Venom of the Scorpion Scorpio maurus palmatus, with a Potent Antiviral Activity Against Hepatitis C Virus and Dengue Virus.

Authors:  Alaa M H El-Bitar; Moustafa Sarhan; Mohamed A Abdel-Rahman; Veronica Quintero-Hernandez; Chie Aoki-Utsubo; Mohsen A Moustafa; Lourival D Possani; Hak Hotta
Journal:  Int J Pept Res Ther       Date:  2019-07-06       Impact factor: 1.931

4.  Scaffold Morphing Approach To Expand the Toolbox of Broad-Spectrum Antivirals Blocking Dengue/Zika Replication.

Authors:  Paolo Vincetti; Suzanne J F Kaptein; Gabriele Costantino; Johan Neyts; Marco Radi
Journal:  ACS Med Chem Lett       Date:  2019-01-23       Impact factor: 4.345

Review 5.  Recent progress on phenotype-based discovery of dengue inhibitors.

Authors:  Fumiaki Yokokawa
Journal:  RSC Med Chem       Date:  2020-04-20

6.  Corona versus Dengue: Distinct Mechanisms for Inhibition of Polyprotein Processing by Antiviral Drugs.

Authors:  Mira A M Behnam; Christian D Klein
Journal:  ACS Pharmacol Transl Sci       Date:  2022-06-24

7.  A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein.

Authors:  Fang Guo; Shuo Wu; Justin Julander; Julia Ma; Xuexiang Zhang; John Kulp; Andrea Cuconati; Timothy M Block; Yanming Du; Ju-Tao Guo; Jinhong Chang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

8.  Looking for inhibitors of the dengue virus NS5 RNA-dependent RNA-polymerase using a molecular docking approach.

Authors:  Vicente Galiano; Pablo Garcia-Valtanen; Vicente Micol; José Antonio Encinar
Journal:  Drug Des Devel Ther       Date:  2016-10-11       Impact factor: 4.162

9.  Design, synthesis and biological evaluation of spiropyrazolopyridone derivatives as potent dengue virus inhibitors.

Authors:  Jimin Xu; Xuping Xie; Haiying Chen; Jing Zou; Yu Xue; Na Ye; Pei-Yong Shi; Jia Zhou
Journal:  Bioorg Med Chem Lett       Date:  2020-03-30       Impact factor: 2.823

10.  Synthetic strategy and antiviral evaluation of diamide containing heterocycles targeting dengue and yellow fever virus.

Authors:  Milind Saudi; Joanna Zmurko; Suzanne Kaptein; Jef Rozenski; Bharat Gadakh; Patrick Chaltin; Arnaud Marchand; Johan Neyts; Arthur Van Aerschot
Journal:  Eur J Med Chem       Date:  2016-05-21       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.